The neuropathic pain sector in North America boasts a valuation of US$ 3,295 million in 2024. Combinations of various treatments are highly favored among patients in this region, allowing physicians to develop medications that effectively target multiple pain circuits simultaneously. The neuropathic pain market was valued at approximately US$ 6,316.6 million in 2019. The combined worth of...